Skip to main content
. Author manuscript; available in PMC: 2020 Oct 23.
Published in final edited form as: Cell Rep. 2020 Oct 6;33(1):108226. doi: 10.1016/j.celrep.2020.108226

Figure 4. The Neutralization Activity of Monoclonal Antibodies (mAbs) against Distinct DENV2 Genotypic Variants.

Figure 4.

(A and B) Memory-B-cell-derived mAbs 2D22 and 3F9.

(C–H) Plasmablast-derived mAbs 1662, 1671-1, 1671-4, 1615, 1628, and 1660.

(I) mAb neutralization IC50 values against DENV2 recombinant viruses. See also Figure S3.